Applied Visual Sciences, Inc.
APVS
Other OTC0.00
USD
- -
- -
ISIN
US0382871087
CUSIP
038287108
Return %
Stock
S&P500
1Y
9,900.00
18.02
3Y
-90.00
64.11
5Y
-98.15
72.15
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- William J. Donovan
- Full Time Employees
- 3
- Sector
- Technology
- Industry
- Software - Application
- Address
- 525K East Market Street Leesburg VA United States of America 20176
- IPO Date
- May 14, 1996
- Website
- appliedvs.com
- Similar Companies
- Business
- Applied Visual Sciences, Inc. is a software technology company that designs and develops computer-vision detection solutions based on image processing science, primarily serving the aviation, homeland security, and healthcare markets. The company offers a range of products including PinPoint, an intelligent computer-vision automated target recognition technology for detecting guns, explosives, and other threat items in baggage within airport environments and building security applications. It also provides the Signature Mapping platform technology used in diagnostic radiology and pathology imaging. This includes the Signature Mapping Detection System, an automated hardware-software laboratory solution for infectious disease applications featuring multi-threaded detection algorithms, as well as the Signature Mapping Tuberculosis Detection software platform and Signature Mapping Breast Cancer Detection solution. Applied Visual Sciences markets its products globally through direct sales and various indirect distribution channels. Founded in 1992 and headquartered in the United States, the company operates primarily through its subsidiary Guardian Technologies International, Inc., which focuses on aviation and homeland security products. Applied Visual Sciences has recently emphasized advancing its computer-vision and image processing capabilities to enhance threat detection and healthcare diagnostics. Notably, within the last two years, Applied Visual Sciences has focused on refining its Signature Mapping platform for disease detection and expanding its product offerings in automated detection systems for critical healthcare applications, including tuberculosis and breast cancer. There is no publicly reported recent major acquisition or strategic alliance disclosed, but the company continues to innovate within its core technology domains and expand its application markets. Applied Visual Sciences integrates imaging technologies and analytics into its product lines to address critical security and healthcare challenges, targeting corporations and governmental agencies worldwide. Its product suite covers security screening technology and diagnostic imaging solutions aimed at improving threat identification and disease diagnostic accuracy. This comprehensive portfolio positions Applied Visual Sciences in the software technology and healthcare diagnostics industry with a strong focus on computer vision and image-based detection systems that serve both security and medical sectors globally.
Critical Analysis: Applied Visual Sciences (OTCMKTS:APVS) versus Park Aerospace (NYSE:PKE)
Applied Visual Sciences (OTCMKTS:APVS) Stock Price Crosses Above 200-Day Moving Average – What’s Next?
Contrasting Applied Visual Sciences (OTCMKTS:APVS) & AerSale (NASDAQ:ASLE)
Comparing Applied Visual Sciences (OTCMKTS:APVS) & Axon Enterprise (NASDAQ:AXON)
Analyzing Applied Visual Sciences (OTCMKTS:APVS) and EHang (NASDAQ:EH)
Applied Visual Sciences (OTCMKTS:APVS) versus Optex Systems (NASDAQ:OPXS) Head-To-Head Comparison
Analyzing Applied Visual Sciences (OTCMKTS:APVS) and Outdoor (NASDAQ:POWW)